News
HAY pharma
[PRESS RELEASE] Standardized medical cannabis for greater patient safety
Düsseldorf, September 2023 – expopharm, Europe’s leading trade fair for the pharmaceutical market, is once again the central meeting place for industry insiders in Düsseldorf this year. In addition to a comprehensive range of pharmaceutical products and services, this year HAY pharma presented its innovative dosage forms for medicinal cannabis developed with pharmacists, including inhalation
HAY Joins the European Medicinal Cannabis Association
We are excited to announce that HAY is now a member of the European Medicinal Cannabis Association (EUMCA). The EUMCA is the authoritative voice for the medicinal cannabis industry sector in Europe, and we are proud to now be a part of this important organization. Sita Schubert, the founder and general secretary of the EUMCA,
HAY STATUS UPDATE 06/23
Dear Investors, we appreciate your continued support and interest in HAY pharma. We are pleased to share with you the latest developments of our company and our future plans.
Raphael Mechoulam – pioneer of cannabis research
Raphael Mechoulam was born in Sofia, Bulgaria, on November 5, 1930. The son of Jewish immigrants from Bulgaria, he grew up in Israel. He studied at the Hebrew University of Jerusalem, where he later began his career as a scientist. After completing his studies in 1952, Mechoulam worked as an officer in the Israeli army
HAY introduces Alexander Rieg as new chief operating officer.
Dortmund, January 2023 – HAY Pharm GmbH is expanding its management team: from January 2023, industry pioneer Alexander Rieg will support the internationally active company as Chief Operating Officer. Alexander Rieg has been an integral part of the medical cannabis industry in Germany for years. Not only is he the founder of `GECA Pharma GmbH’,
HAY pharma receives GMP certification
HAY pharma (“HAY” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice) approval for both facilities.This milestone demonstrates HAY’s commitment towards stringent quality assurance on premises and